Editas Medicine (EDIT) Reports Q4 Loss of $0.52/Share

Editas Medicine (NASDAQ: EDIT) reported Q4 EPS of ($0.52), versus ($0.84) reported last year.

For earnings history and earnings-related data on Editas Medicine (EDIT) click here.

You May Also Be Interested In

• Guggenheim Upgrades Editas Medicine (EDIT) to Buy
• Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
• On Holding AG (ONON) Stock: Market Doesn't Appreciate Brand's Potential, Says Analyst